- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Pharmaceuticals - Community Register
Community register of medicinal products for human use |
AUTHORISED |
Product information |
| Invented name: | NexoBrid
|
| Auth. number : | EU/1/12/803 |
| Active substance : | Concentrate of proteolytic enzymes enriched in bromelain |
| Orphan market exclusivity for "Treatment of partial deep dermal and full thickness burns" (based on designation EU/3/02/107) started on 20/12/2012 10 years of market exclusivity This orphan market exclusivity will expire on 20/12/2022 | |
| ATC: | Anatomical main group: D - Dermatologicals Therapeutic subgroup: D03 - Preparations for treatment of wounds & ulcers Pharmacological subgroup: D03B - Enzymes Chemical subgroup: D03BA - Proteolytic enzymes Chemical substance: D03BA03 - Bromelains (See WHO ATC Index) |
| Indication: | NexoBrid is indicated for removal of eschar in adults with deep partial- and full-thickness thermal burns. |
| Marketing Authorisation Holder: | MediWound Germany GmbH
Eisenstr. 5, D-65428 Ruesselsheim, Deutschland |
|
EPAR and active package presentations | |
Package presentations | |
|
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register. |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 20/12/2012 | Centralised - Authorisation | EMEA/H/C/2246 | (2012)9858 of 18/12/2012 | |||
| 23/09/2013 | Centralised - Transfer Marketing Authorisation Holder | EMEA/H/C/2246/T/2 | (2013)6218 of 19/09/2013 | |||
| 29/10/2013 | Centralised - Variation | EMEA/H/C/2246/IA/4/G | ||||
| Updated with Decision(2014)8295 of 30/10/2014 | ||||||
| 18/06/2014 | Centralised - Variation | EMEA/H/C/2246/IA/15/G | ||||
| Updated with Decision(2014)8295 of 30/10/2014 | ||||||
| 21/08/2014 | Centralised - Variation | EMEA/H/C/2246/II/9 | ||||
| Updated with Decision(2014)8295 of 30/10/2014 | ||||||
| 03/11/2014 | Centralised - Yearly update | (2014)8295 of 30/10/2014 |


